
Healthcare investments wane after strong Q2

Investment in the healthcare industry is facing tough times as total deal value falls to its lowest level in 18 months.
Healthcare is an industry that has traditionally enjoyed a reputation as a crisis-proof safe-haven. When times are hard, many say that healthcare and technology investments are a good choice, mostly because of societal demand in, for example, medical research.
But as economic conditions worsen, the healthcare sector is also struggling.
Having experienced declining dealflow since Q1 2011, the industry saw a surge in activity at the beginning of this year. Indeed, with 35 deals totalling more than €3.5bn between April and June 2012, investment almost reached the peak of the previous year.
Following the success, however, was the slump. Healthcare investments fell to an all time low in the time period considered, some of which may be attributed to the slow summer business.
But the field is dealing with more than just crisis-related issues. As unquote" reported, the British healthcare industry is bracing itself for major reforms, which could potentially change the investment landscape forever.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater